• |
  • |
  • |
  • |
Donate

Product

Journal: Brain Metabolomics in Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS)

Center:
Fiscal Year:
2024
Contact Information:
Product Description:
Our study identified alterations in the metabolites involved in the oxidative-stress response and bioenergetics in the brains of individuals with FXTAS. Significant changes in the abundance of cytidine and oleamide suggest their potential as biomarkers and therapeutic targets for FXTAS.
Keyword(s):
Fragile X, Metabolomics, Ataxia Syndrome
Product/Publication Type(s):
Peer-reviewed publications in scholarly journals Published/In Press
Target Audience:
Professionals, Students
Alternative Format:
To Obtain Copies (URL or Email):
COVID-19 Related Data:
N/A